Patients with plasma cell disorders examined at whole-body dynamic contrast-enhanced MR imaging: Initial experience

Radiology

Volumn 250, Issue 3, 2009, Pages 905-915

  Lin, Chieh ^a,b,c   Luciani, Alain ^a,b,e   Belhadj, Karim ^a,b   Maison, Patrick ^a,b   Vignaud, Alexandre ^d   Deux, Jean François ^a,b,e   Zerbib, Pierre ^a   Pigneur, Frédéric ^a,b   Itti, Emmanuel ^a,b   Kobeiter, Hicham ^a,b,e   Haioun, Corinne ^a,b   Rahmouni, Alain ^a,b  

^a HENRI MONDOR HOSPITAL   (France)

^b FACULTÉ DE MÉDECINE   (France)

^c INSERM   (France)

^d SIEMENS AG   (Germany)

^e CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM;

ADULT; AGED; ARTICLE; BONE MARROW; CELL INFILTRATION; CLINICAL ARTICLE; FEASIBILITY STUDY; FEMALE; HUMAN; IMAGE ENHANCEMENT; INFORMED CONSENT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA CELL; PLASMA CELL DISORDER; PRIORITY JOURNAL; PROSPECTIVE STUDY; THREE DIMENSIONAL ECHOCARDIOGRAPHY; WHOLE BODY IMAGING;

ADULT; AGED; CONTRAST MEDIA; FEASIBILITY STUDIES; FEMALE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PILOT PROJECTS; PLASMA CELLS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; WHOLE BODY IMAGING;

EID: 62749112868     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2503081017     Document Type: Article

References (39)

1. Rajkumar SV, Leong T, Roche PC, et al. Prognostic value of bone marrow angiogenesis in multiple myeloma. Clin Cancer Res 2000;6: 3111-3116.
2. Rajkumar SV, Mesa RA, Fonseca R, et al. Bone marrow angiogenesis in 400 patients with monoclonal gammopathy of undetermined significance, multiple myeloma, and primary amyloidosis. Clin Cancer Res 2002;8:2210-2216.
3. Rajkumar SV, Hayman S, Greipp PR. Angiogenesis in Waldenstrom's macroglobulinemia. Semin Oncol 2003;30:262-264.
4. Kumar S, Fonseca R, Dispenzieri A, et al. Prognostic value of angiogenesis in solitary bone plasmacytoma. Blood 2003;101:1715-1717.
5. Bhatti SS, Kumar L, Dinda AK, Dawar R. Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters. Am J Hematol 2006;81: 649-656.
6. Sezer O, Niemoller K, Eucker J, et al. Bone marrow microvessel density is a prognostic factor for survival in patients with multiple myeloma. Ann Hematol 2000;79:574-577.
7. Kumar S, Gertz MA, Dispenzieri A, et al. Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy. Bone Marrow Transplant 2004;34:235-239.
8. Moehler TM, Hawighorst H, Neben K, et al. Bone marrow microcirculation analysis in multiple myeloma by contrast-enhanced dynamic magnetic resonance imaging. Int J Cancer 2001;93:862-868.
9. Rahmouni A, Montazel JL, Divine M, et al. Bone marrow with diffuse tumor infiltration in patients with lymphoproliferative diseases: dynamic gadolinium-enhanced MR imaging. Radiology 2003;229:710-717.
10. Baur A, Bartl R, Pellengahr C, Baltin V, Reiser M. Neovascularizationofbonemarrowinpatientswith diffuse multiple myeloma: a correlative study of magnetic resonance imaging and histopathologic findings. Cancer 2004;101:2599-2604.
11. Nosas-Garcia S, Moehler T, Wasser K, et al. Dynamic contrast-enhanced MRI for assessing the disease activity ofmultiple myeloma: a comparative study with histology and clinical markers. J Magn Reson Imaging 2005;22:154-162.
12. Hillengass J, Wasser K, Delorme S, et al. Lumbar bone marrow microcirculation measurements from dynamic contrast-enhanced magnetic resonance imaging is a predictor of event-free survival in progressive multiple myeloma. Clin Cancer Res 2007;13:475-481.
13. Rahmouni A, Divine M, Mathieu D, et al. MR appearance of multiple myeloma of the spine before and after treatment. AJR Am J Roentgenol 1993;160:1053-1057.
14. Lecouvet FE, Malghem J, Michaux L, et al. Skeletal survey in advanced multiple myeloma: ra-diographic versus MR imaging survey. Br J Haematol 1999;106:35-39.
15. Huang SY, Yao M, Tang JL, et al. Epidemiology of multiple myeloma in Taiwan: increasing incidence for the past 25 years and higher prevalence of extramedullary myeloma in patients younger than 55 years. Cancer 2007;110:896-905.
16. Schmidt GP, Baur-Melnyk A, Herzog P, et al. High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system. Invest Radiol 2005;40:743-753.
17. Schmidt GP, Schoenberg SO, Reiser MF, Baur-Melnyk A. Whole-body MR imaging of bone marrow. Eur J Radiol 2005;55:33-40.
18. Ghanem N, Lohrmann C, Engelhardt M, et al. Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to the radiological skeletal survey. Eur Radiol 2006;16:1005-1014.
19. Baur-Melnyk A, Buhmann S, Becker C, et al. Whole-body MRI versus whole-body MDCT for staging of multiple myeloma. AJR Am J Roentgenol 2008;190:1097-1104.
20. Rofsky NM, Lee VS, Laub G, et al. Abdominal MR imaging with a volumetric interpolated breath-hold examination. Radiology 1999;212: 876 -884.
21. Lauenstein TC, Goehde SC, Herborn CU, et al. Three-dimensional volumetric interpolated breath-hold MR imaging for whole-body tumor staging in less than 15 minutes: a feasibility study. AJR Am J Roentgenol 2002;179:445-449.
22. Parker GJ, Suckling J, Tanner SF, Padhani AR, Husband JE, Leach MO. MRIW: parametric analysis software for contrast-enhanced dynamic MR imaging in cancer. RadioGraphics 1998;18:497-506.
23. Kuo PH, Kanal E, Abu-Alfa AK, Cowper SE. Gadolinium-based MR contrast agents and nephrogenic systemic fibrosis. Radiology 2007;242:647-649.
24. Griswold MA, Jakob PM, Heidemann RM, et al. Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Reson Med 2002;47:1202-1210.
25. Ruel L, Brugieres P, Luciani A, Breil S, Mathieu D, Rahmouni A. Comparison of in vitro and in vivo MRI of the spine using parallel imaging. AJR Am J Roentgenol2004;182:749-755.
26. Reeder SB, Wintersperger BJ, Dietrich O, et al. Practical approaches to the evaluation of signal-to-noise ratio performance with parallel imaging: application with cardiac imaging and a 32-channel cardiac coil. Magn Reson Med 2005;54:748-754.
27. Ricci C, Cova M, Kang YS, et al. Normal agerelated patterns of cellular and fatty bone marrow distribution in the axial skeleton: MR imaging study. Radiology 1990;177:83-88.
28. Montazel JL, Divine M, Lepage E, Kobeiter H, Breil S, Rahmouni A. Normal spinal bone marrow in adults: dynamic gadolinium-enhanced MR imaging. Radiology 2003;229:703-709.
29. Moulopoulos LA, Dimopoulos MA, Alexanian R, Leeds NE, Libshitz HI. Multiple myeloma: MR patterns of response to treatment. Radiology 1994;193:441-446.
30. Stabler A, Baur A, Bartl R, Munker R, Lamerz R, Reiser MF. Contrast enhancementand quantitative signal analysis in MR imaging ofmultiple myeloma: assessment of focal and diffuse growth patterns in marrow correlated with biopsies and survival rates. AJR Am J Roentgenol 1996;167:1029-1036.
31. Durie BG. The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system. Eur J Cancer 2006;42:1539-1543.
32. Kuhl C. The current status of breast MR imaging. I. Choice of technique, image interpretation, diagnostic accuracy, and transfer to clinical practice. Radiology 2007;244:356-378.
33. Rahmouni A, Divine M, Mathieu D, et al. Detection of multiple myeloma involving the spine: efficacy of fat-suppression and contrast-enhanced MR imaging. AJR Am J Roentgenol 1993;160:1049-1052.
34. Kuhl CK, Mielcareck P, Klaschik S, et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions? Radiology 1999;211: 101-110.
35. Rajkumar SV, Kyle RA. Multiple myeloma: diagnosis and treatment. Mayo Clin Proc 2005;80:1371-1382.
36. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
37. Weininger M, Lauterbach B, Knop S, et al. Whole-bodyMRI ofmultiple myeloma: comparison of different MRI sequences in assessment of different growth patterns. Eur J Radiol doi: 10.1016/j.ejrad.2007.10.025. Published online December 18, 2007. Accessed December 18, 2007.
38. Thomson V, PialatJB, GayF, etal. Whole-body MRI for metastases screening: a preliminary study using 3D VIBE sequences with automatic subtraction between noncontrast and contrast enhanced images. Am J Clin Oncol 2008;31: 285-292.
39. Monill J, Pernas J, Montserrat E, et al. CT features of abdominal plasma cell neoplasms. Eur Radiol 2005;15:1705-1712.